help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ezzat, S.
Right arrow Articles by Asa, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ezzat, S.
Right arrow Articles by Asa, S. L.
(American Journal of Pathology. 2003;163:1177-1184.)
© 2003 American Society for Investigative Pathology

Ikaros Isoforms in Human Pituitary Tumors

Distinct Localization, Histone Acetylation, and Activation of the 5' Fibroblast Growth Factor Receptor-4 Promoter

Shereen Ezzat*, Shunjiang Yu* and Sylvia L. Asa{dagger}

From the Department of Medicine,*Mount Sinai Hospital, and the Department of Pathology,{dagger}University Health Network, University of Toronto, The Freeman Centre for Endocrine Oncology, and The Ontario Cancer Institute, Toronto, Ontario, Canada

Targeted expression of a human pituitary tumor derived-fibroblast growth factor receptor-4 (FGFR4) recapitulates pituitary tumorigenesis. We have shown that FGFR4 is a target for Ikaros, a zinc finger-containing transcription factor that localizes to heterochromatin regions and participates in higher order chromatin complexes and control of gene expression. We report here the expression of Ikaros and functional differences between its alternatively spliced variants in human pituitary tumors. Ik1 expression was detected in human pituitary tumors and we also identified a truncated isoform consistent with the non-DNA-binding Ik6 isoform in a subset of adenomas by reverse transcriptase-polymerase chain reaction, sequencing, and Western immunoblotting. Transfection of Ik6 in GH4 pituitary cells resulted in predominantly cytoplasmic expression as compared to Ik1, which resulted in exclusively nuclear expression as determined by immunofluorescence and immunoblotting of fractionated protein. Immunohistochemistry of primary human pituitary adenomas localized Ikaros expression to the nuclear compartment but also in the cytoplasm, the latter consistent with Ik6. Expression of Ikaros and truncated non-DNA-binding isoforms was also suggested by electromobility shift assays using nuclear proteins from primary human pituitary adenomas. Ik6 resulted in reversal of the effects of Ik1 on wild-type 5' FGFR4 promoter activity, histone acetylation, and regulation of the endogenous gene. We conclude that dominant-negative Ik6 isoforms with their distinct localization and effects on Ik1 action may contribute to the altered expression of FGFR4 and possibly other target genes in human pituitary tumors.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
X. Zhu, X. Mao, R. Hurren, A. D. Schimmer, S. Ezzat, and S. L. Asa
Deoxyribonucleic Acid Methyltransferase 3B Promotes Epigenetic Silencing through Histone 3 Chromatin Modifications in Pituitary Cells
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3610 - 3617.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. Ezzat and S. L Asa
The emerging role of the Ikaros stem cell factor in the neuroendocrine system
J. Mol. Endocrinol., August 1, 2008; 41(2): 45 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Loeper, S. L. Asa, and S. Ezzat
Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation
Cancer Res., May 15, 2008; 68(10): 3715 - 3723.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Zhu, S. L. Asa, and S. Ezzat
Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia
Clin. Cancer Res., April 1, 2008; 14(7): 1984 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Kondo, X. Zhu, S. L. Asa, and S. Ezzat
The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer
Clin. Cancer Res., August 15, 2007; 13(16): 4713 - 4720.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
X. Zhu, S. L. Asa, and S. Ezzat
Ikaros Is Regulated through Multiple Histone Modifications and Deoxyribonucleic Acid Methylation in the Pituitary
Mol. Endocrinol., May 1, 2007; 21(5): 1205 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
X. Zhu, K. Lee, S. L. Asa, and S. Ezzat
Epigenetic Silencing through DNA and Histone Methylation of Fibroblast Growth Factor Receptor 2 in Neoplastic Pituitary Cells
Am. J. Pathol., May 1, 2007; 170(5): 1618 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. A. Boikos and C. A. Stratakis
Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis
Hum. Mol. Genet., April 15, 2007; 16(R1): R80 - R87.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Ezzat, L. Zheng, D. Winer, and S. L. Asa
Targeting N-Cadherin through Fibroblast Growth Factor Receptor-4: Distinct Pathogenetic and Therapeutic Implications
Mol. Endocrinol., November 1, 2006; 20(11): 2965 - 2975.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Ezzat, X. Zhu, S. Loeper, S. Fischer, and S. L. Asa
Tumor-Derived Ikaros 6 Acetylates the Bcl-XL Promoter to Up-Regulate a Survival Signal in Pituitary Cells
Mol. Endocrinol., November 1, 2006; 20(11): 2976 - 2986.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Ezzat, R. Mader, S. Fischer, S. Yu, C. Ackerley, and S. L. Asa
An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growth
PNAS, February 14, 2006; 103(7): 2214 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S Ezzat and S L Asa
The molecular pathogenetic role of cell adhesion in endocrine neoplasia
J. Clin. Pathol., November 1, 2005; 58(11): 1121 - 1125.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Ezzat, S. Yu, and S. L. Asa
The Zinc Finger Ikaros Transcription Factor Regulates Pituitary Growth Hormone and Prolactin Gene Expression through Distinct Effects on Chromatin Accessibility
Mol. Endocrinol., April 1, 2005; 19(4): 1004 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Ezzat, L. Zheng, and S. L. Asa
Pituitary Tumor-Derived Fibroblast Growth Factor Receptor 4 Isoform Disrupts Neural Cell-Adhesion Molecule/N-Cadherin Signaling to Diminish Cell Adhesiveness: A Mechanism Underlying Pituitary Neoplasia
Mol. Endocrinol., October 1, 2004; 18(10): 2543 - 2552.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. R. Qian, T. Sano, S. L. Asa, S. Yamada, H. Horiguchi, T. Tashiro, C. C. Li, M. Hirokawa, K. Kovacs, and S. Ezzat
Cytoplasmic Expression of Fibroblast Growth Factor Receptor-4 in Human Pituitary Adenomas: Relation to Tumor Type, Size, Proliferation, and Invasiveness
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1904 - 1911.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.